# Editorial: New marketable discoveries in nanobiotechnology

**Authors:** Ronnie G. Willaert, Sandor Kasas

PMC · DOI: 10.3389/fbioe.2024.1412587 · 2024-04-19

## Full-text entities

- **Diseases:** toxicity (MESH:D064420), cardiotoxicity (MESH:D066126), chondral and osseous deformities (MESH:C535395), thyroid disease (MESH:D013959), bacterial (MESH:D001424)
- **Chemicals:** 3- chloromethylene-menadione (-), chitosan (MESH:D048271), Famotidine (MESH:D015738), naphthoquinone (MESH:D009285), 2,3-dichloro-1,4-naphthoquinone (MESH:C007332), CNP (MESH:C010422)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus epidermidis (species) [taxon 1282], Staphylococcus aureus (species) [taxon 1280], Rattus norvegicus (brown rat, species) [taxon 10116], Streptococcus pyogenes (species) [taxon 1314], Pseudomonas aeruginosa (species) [taxon 287]

---
Source: https://tomesphere.com/paper/PMC11066226